Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | April 30, 2024 04:31pm

Gainers

  • Predictive Oncology (NASDAQ:POAI) shares rose 36.4% to $1.95 during Tuesday's after-market session. The company's market cap stands at $7.9 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares moved upwards by 18.25% to $0.45. The company's market cap stands at $30.5 million.
  • Telomir Pharmaceuticals (NASDAQ:TELO) stock increased by 12.92% to $7.34. The market value of their outstanding shares is at $217.3 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 11.24% to $2.87. The market value of their outstanding shares is at $30.1 million.
  • TransMedics Gr (NASDAQ:TMDX) shares moved upwards by 11.02% to $104.51. The company's market cap stands at $3.4 billion. As per the press release, Q1 earnings came out today.
  • Akari Therapeutics (NASDAQ:AKTX) shares moved upwards by 10.0% to $1.54. The market value of their outstanding shares is at $12.2 million.

Losers

  • Concord Medical Services (NYSE:CCM) stock declined by 23.3% to $0.65 during Tuesday's after-market session. The company's market cap stands at $28.3 million.
  • CVRx (NASDAQ:CVRX) shares declined by 16.19% to $13.0. The market value of their outstanding shares is at $280.7 million. As per the press release, Q1 earnings came out today.
  • Mereo BioPharma Group (NASDAQ:MREO) stock declined by 8.53% to $2.79. The company's market cap stands at $391.3 million.
  • BiomX (AMEX:PHGE) stock declined by 8.15% to $0.44. The market value of their outstanding shares is at $24.2 million.
  • 10x Genomics (NASDAQ:TXG) stock fell 8.13% to $26.9. The market value of their outstanding shares is at $3.2 billion. The company's, Q1 earnings came out today.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares fell 7.08% to $1.97. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKTX BCLI CCM CVRX CYCC MREO NRXP PHGE POAI TELO TMDX TXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist